NCT04382495

Brief Summary

The situation of COVID-19 pandemic creates many challenges for cancer patients and caregivers. Some modifications in cancer management have been evolved from cancer societies and organizations to support oncology professionals as much as possible to deliver optimal care to their cancer patients in such exceptional circumstances, and to protect patients from infection with COVID-19 as much as possible.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 11, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

June 15, 2020

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2022

Completed
Last Updated

August 28, 2024

Status Verified

August 1, 2024

Enrollment Period

1.5 years

First QC Date

May 8, 2020

Last Update Submit

August 27, 2024

Conditions

Cancer

Keywords

Cancer CareCOVID-19

Outcome Measures

Primary Outcomes (1)

  • patients' and survivors' perspective of their cancer care during COVID-19 pandemic

    measured by online survey to understand the impact of COVID-19 pandemic on cancer care

    one month

Interventions

surveyOTHER

online survey

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

the study survey will be distributed through social media to cancer patients and survivors in Egypt. We plan to enroll as many participants as possible without limitation of the number although we hope to achieve at least 400 participants.

You may qualify if:

  • cancer patients or survivors in Egypt.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

EgyBrit Medical Centre

Cairo, 00202, Egypt

Location

MeSH Terms

Conditions

NeoplasmsCOVID-19

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Ahmed Abdelaziz, MD

    Ain Shams University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

May 8, 2020

First Posted

May 11, 2020

Study Start

June 15, 2020

Primary Completion

December 1, 2021

Study Completion

January 30, 2022

Last Updated

August 28, 2024

Record last verified: 2024-08

Locations

EG(1)